TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/03 | 2022/03 | 2021/03 |
Turnover |
28,935
|
29,607
|
34,891 |
Financial expenses |
104
|
521
|
409 |
Earnings before taxes |
1,319
|
1,056
|
1,659 |
EBITDA |
1,424
|
1,086
|
1,762 |
Total assets |
37,058
|
32,536
|
31,633 |
Current assets |
37,058
|
32,536
|
31,633 |
Current liabilities |
12,072
|
7,816
|
7,393 |
Equity capital |
24,986
|
24,720
|
24,240 |
- share capital |
164
|
163
![]() |
163 |
Employees (average) |
16
|
18
|
19 |
Financial ratios
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Solvency |
67.4%
|
76.0%
|
76.6% |
Turnover per employee |
1,808
|
1,645
|
1,836 |
Profit as a percentage of turnover |
4.6%
|
3.6%
|
4.8% |
Return on assets (ROA) |
3.8%
|
4.8%
|
6.5% |
Current ratio |
307.0%
|
416.3%
|
427.9% |
Return on equity (ROE) |
5.3%
|
4.3%
|
6.8% |
Change turnover |
1,751
|
-4,947
|
-12,118 |
Change turnover % |
6%
|
-14%
|
-26% |
Chg. No. of employees |
-2
|
-1
![]() |
-1 |
Chg. No. of employees % |
-11%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.